Regulatory News
Tuesday, June 28, 2016
BRIEF-U.S. FDA says continues to find benefits of flumist quadrivalent outweigh any potential risks
* FDA continues to find that the benefits of flumist
quadrivalent outweigh any potential risks
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment